EBIT: Income before interest and taxes.
NextCure, Inc. (NXTC) had EBIT of $-67.64M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-62.72M |
|
-- |
|
-- |
|
$67.64M |
|
$-67.64M |
|
$4.91M |
|
$-62.72M |
|
$-62.72M |
|
$-62.72M |
|
$-62.72M |
|
$-62.72M |
|
$-62.72M |
|
|
EBIT |
$-67.64M |
$-64.71M |
|
27.84M |
|
27.84M |
|
$-2.25 |
|
$-2.25 |
|
| Balance Sheet Financials | |
$112.72M |
|
$9.03M |
|
$15.31M |
|
$128.04M |
|
$6.88M |
|
-- |
|
$6.73M |
|
$13.62M |
|
$114.42M |
|
$114.42M |
|
$114.42M |
|
27.90M |
|
| Cash Flow Statement Financials | |
$-52.97M |
|
$39.27M |
|
$0.15M |
|
$26.63M |
|
$13.08M |
|
$-13.55M |
|
$8.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-53.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.82% |
|
-54.82% |
|
-48.99% |
|
-54.82% |
|
$4.10 |
|
$-1.93 |
|
$-1.90 |
|